Human Liver Models Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Human Liver Models Market is segmented by Product Type (2D Models, 3D Models, Liver-on-a-Chip, Others), Application and Geography

Human Liver Models Market Snapshot

Human Liver Models Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global human liver models market is expected to witness CAGR of 13.5% over the forecast period. The growth is primarily attributed to increasing research and development in healthcare, increasing prevalence of liver diseases and advancements in organ printing technologies. In addition, the increasing focus on developing alternatives for the animal-based models and accuracy in outcomes is projected to boost the market growth. Moreover, increasing prevalence of the non-fatty acid liver disease, alcohol consumption that is leading to liver diseases is anticipated to fuel the market growth over the forecast period. However, the high cost of liver models and issues with the incorporation of liver models into existing workflow are expected to hamper the market growth over the forecast period.

Scope of the Report

Liver is an important organ that performs vital body functions such as synthesis of blood clotting factors, bile production, protein production and detoxification. Human liver models are used to study the toxicity of the drug and enable understanding of the effect of drugs and the progression of liver disease.

By Product Type
2D Models
3D Models
Drug Discovery
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Liver-on-a-Chip liver models are expected to Grow at Significant Rate

Liver-on-a-Chip is the bioengineered systems that are able to simulate the key features of the fundamental function of the liver. Liver-on -a-chip are simpler and less expensive compared to other models. Furthermore, owing to the growing demand for low-cost alternatives for animal models for drug discovery and development, the segment is projected to grow at significant rates. The increase in initiatives for liver organoids and technological advancements in human organ modelling is anticipated to fuel the overall market growth.

Moreover, increasing liver infections and use of liver models in the development of many drugs is expected to boost the market growth over the forecast period. According to Center for Disease Control and Prevention (CDC), each year in the United States, about 21,000 men and 8,000 women get liver cancer, and about 16,000 men and 8,000 women die from the disease. Also, the increase in consumption of the alcohol around the world is leading to the liver diseases increasing the demand for liver models.

Human Liver Models Market

North America is Expected to have Significant Market Share

North America and Europe are expected to have the majority of the market share owing to increasing R&D expenditure, innovation in the organ models and adoption of innovative potential therapies in the region. Moreover, increasing prevalence of liver diseases coupled with the presence of key market players in the region is anticipated to boost the market growth over the forecast period. Asia Pacific region is expected to expand its share due to increasing R&D investments in developing countries of the region. Moreover, developing healthcare infrastructure and companies focus on the development of new therapeutics expected to bolster regional growth.

Human Liver Models Market

Competitive Landscape

Global human liver models market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in the market include Emulate, Inc., InSphero,  BioIVT, Organovo Holdings Inc., and Mimetas  among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Chronic Diseases and Geriatric Population

      2. 4.2.2 Increasing Demand For Technologically Advanced Stretchers

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Specialized Stretchers

      2. 4.3.2 Growing Adoption of Home Healthcare

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 2D Models

      2. 5.1.2 3D Models

      3. 5.1.3 Liver-on-a-Chip

      4. 5.1.4 Others

    2. 5.2 Application

      1. 5.2.1 Eduction

      2. 5.2.2 Drug Discovery

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Organovo Holdings Inc.

      2. 6.1.2 BioIVT

      3. 6.1.3 InSphero

      4. 6.1.4 Emulate, Inc.

      5. 6.1.5 Mimetas

      6. 6.1.6 CN Bio

      7. 6.1.7 Cyfuse Biomedical K.K.

      8. 6.1.8 HuREL Corporation

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Human Liver Models Market market is studied from 2018 - 2026.

The Human Liver Models Market is growing at a CAGR of 13.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Emulate, Inc., InSphero, BioIVT, Organovo Holdings Inc., Mimetas are the major companies operating in Human Liver Models Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!